WO2025094081 - SOLID STATE FORMS OF DEUTIVACAFTOR
National phase entry:
Publication Number
WO/2025/094081
Publication Date
08.05.2025
International Application No.
PCT/IB2024/060714
International Filing Date
30.10.2024
Title **
[English]
SOLID STATE FORMS OF DEUTIVACAFTOR
[French]
FORMES À L'ÉTAT SOLIDE DE DEUTIVACAFTOR ET PROCÉDÉ ASSOCIÉ
Applicants **
ASSIA CHEMICAL INDUSTRIES LTD.
Inventors
JANTON, Nikolina
PERKOVIC, Zvonimir
Priority Data
63/594,160
30.10.2023
US
63/607,286
07.12.2023
US
63/549,631
05.02.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2571 | |
| EPO | Filing, Examination, Granting | 14337 | |
| Japan | Filing, Examination, Granting | 2533 | |
| South Korea | Filing, Examination, Granting | 2967 | |
| USA | Filing, Examination, Granting | 12340 |
Total:
34,748
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure relates to Deutivacaftor solid state forms, processes for preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.[French]
La présente divulgation concerne des formes à l'état solide de Deutivacaftor, des procédés de préparation de celles-ci, des compositions pharmaceutiques associées, et des procédés d'utilisation de celles-ci.